Mawana Sugars Limited
MAWANASUG · NSE · Consumer Defensive
StocksWizard rates Mawana Sugars Limited a Buy, scoring 69/100 on our blended model. At ₹109.41 it trades below our blended DCF and relative-multiples fair value of ₹218.82, implying roughly 100% upside to that estimate — we read the stock as undervalued by 100%. Financial health scores 35/100 (grade D). It clears 7 of 11 investability checks, with durability 38, valuation 99 and momentum 95 on our 0–100 scales.
These are StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
With a 20% margin of safety, our buy-below price is ₹175.06. Low-confidence estimate — limited data.
Investability checklist
- ✕ROE above 15%7.3%
- ✕Low debt (D/E < 0.5)0.80x
- ✓Positive free cash flow
- ✕Revenue growth > 10%8%
- ✓Earnings growing2%
- ✕Net margin ≥ 10%2.4%
- ✓Current ratio > 1.51.57
- ✓Below our fair value
- ✓Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- –Altman Z in safe zone
- –Piotroski ≥ 7
1-year price
EOD · 2026-06-19Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Shareholding
Promoter holding via insider stake; institutional via reported holdings.
Key fundamentals
SWOT snapshot
Weaknesses
- •Low return on equity (7.3%).
Opportunities
- •Trading in our value buy zone versus sector peers.
- •Trades ~100% below our estimated fair value.
About Mawana Sugars Limited
Mawana Sugars Limited manufactures and sells sugar products in India. The company operates through Sugar, Power, and Distillery segments. It produces plantation white, refined, and specialty sugars, as well as IP grade sugar for pharmaceutical applications
More in Consumer Defensive
All stocksOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.